Search

Louise Wang Zhiying Humphrey

Examiner (ID: 17515)

Most Active Art Unit
1648
Art Unit(s)
1657, 1648
Total Applications
628
Issued Applications
269
Pending Applications
52
Abandoned Applications
313

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7580311 [patent_doc_number] => 20110294194 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-01 [patent_title] => 'EFFICIENT CELL CULTURE SYSTEM FOR HEPATITIS C VIRUS GENOTYPE 2B' [patent_app_type] => utility [patent_app_number] => 13/059130 [patent_app_country] => US [patent_app_date] => 2009-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 16792 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0294/20110294194.pdf [firstpage_image] =>[orig_patent_app_number] => 13059130 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/059130
Efficient cell culture system for hepatitis C virus genotype 2B Jul 23, 2009 Issued
Array ( [id] => 5993603 [patent_doc_number] => 20110015256 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-20 [patent_title] => 'DELIVERY OF RESTRICTION ENDONUCLEASES TO TREAT HIV, CANCER, AND OTHER MEDICAL CONDITIONS' [patent_app_type] => utility [patent_app_number] => 12/504279 [patent_app_country] => US [patent_app_date] => 2009-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6587 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20110015256.pdf [firstpage_image] =>[orig_patent_app_number] => 12504279 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/504279
DELIVERY OF RESTRICTION ENDONUCLEASES TO TREAT HIV, CANCER, AND OTHER MEDICAL CONDITIONS Jul 15, 2009 Abandoned
Array ( [id] => 6530985 [patent_doc_number] => 20100221264 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-02 [patent_title] => 'Inhibition of HIV-1 Replication by Disruption of the Processing of the Viral Capsid-Spacer Peptide 1 Protein' [patent_app_type] => utility [patent_app_number] => 12/498157 [patent_app_country] => US [patent_app_date] => 2009-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 19047 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20100221264.pdf [firstpage_image] =>[orig_patent_app_number] => 12498157 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/498157
Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein Jul 5, 2009 Issued
Array ( [id] => 7776529 [patent_doc_number] => 20120039984 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-16 [patent_title] => 'GLYCOPEPTIDE AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/002180 [patent_app_country] => US [patent_app_date] => 2009-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 49470 [patent_no_of_claims] => 91 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20120039984.pdf [firstpage_image] =>[orig_patent_app_number] => 13002180 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/002180
GLYCOPEPTIDE AND USES THEREOF Jul 1, 2009 Abandoned
Array ( [id] => 5315963 [patent_doc_number] => 20090280561 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-12 [patent_title] => 'FUSION PROTEIN OF HIV REGULATORY/ACCESSORY PROTEINS' [patent_app_type] => utility [patent_app_number] => 12/490424 [patent_app_country] => US [patent_app_date] => 2009-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7588 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20090280561.pdf [firstpage_image] =>[orig_patent_app_number] => 12490424 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/490424
Fusion protein of HIV regulatory/accessory proteins Jun 23, 2009 Issued
Array ( [id] => 6280654 [patent_doc_number] => 20100119551 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-13 [patent_title] => 'Methods and reagents for vaccination which generate a CD8 T cell immune response' [patent_app_type] => utility [patent_app_number] => 12/456699 [patent_app_country] => US [patent_app_date] => 2009-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 19567 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20100119551.pdf [firstpage_image] =>[orig_patent_app_number] => 12456699 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/456699
Methods and reagents for vaccination which generate a CD8 T cell immune response Jun 18, 2009 Abandoned
Array ( [id] => 6536383 [patent_doc_number] => 20100124553 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-20 [patent_title] => 'Methods for Treatment of HIV and Other Infections Using A T Cell or Viral Activator and Anti-Retroviral Combination Therapy' [patent_app_type] => utility [patent_app_number] => 12/486733 [patent_app_country] => US [patent_app_date] => 2009-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6475 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20100124553.pdf [firstpage_image] =>[orig_patent_app_number] => 12486733 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/486733
Methods for Treatment of HIV and Other Infections Using A T Cell or Viral Activator and Anti-Retroviral Combination Therapy Jun 16, 2009 Abandoned
Array ( [id] => 8421568 [patent_doc_number] => 08278056 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-02 [patent_title] => 'Detection of early stages and late stages HPV infection' [patent_app_type] => utility [patent_app_number] => 12/456076 [patent_app_country] => US [patent_app_date] => 2009-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 56 [patent_no_of_words] => 25703 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 184 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12456076 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/456076
Detection of early stages and late stages HPV infection Jun 9, 2009 Issued
Array ( [id] => 6348269 [patent_doc_number] => 20100021427 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-28 [patent_title] => 'Use of Antiviral Peptides For Treatment of Infections Caused by Drug-Resistant HIV' [patent_app_type] => utility [patent_app_number] => 12/474702 [patent_app_country] => US [patent_app_date] => 2009-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11843 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20100021427.pdf [firstpage_image] =>[orig_patent_app_number] => 12474702 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/474702
Use of Antiviral Peptides For Treatment of Infections Caused by Drug-Resistant HIV May 28, 2009 Abandoned
Array ( [id] => 5304122 [patent_doc_number] => 20090298774 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-03 [patent_title] => 'Bifunctional Molecules for Inhibiting HIV Entry' [patent_app_type] => utility [patent_app_number] => 12/474105 [patent_app_country] => US [patent_app_date] => 2009-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 9048 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20090298774.pdf [firstpage_image] =>[orig_patent_app_number] => 12474105 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/474105
Bifunctional molecules for inhibiting HIV entry May 27, 2009 Issued
Array ( [id] => 5458191 [patent_doc_number] => 20090258343 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-15 [patent_title] => 'Semi-quantitative immunochromatographic device and method for the determination of HIV/AIDS immune-status via measurement of soluble CD40 Ligand/CD154, A CD4+ T cell equivalent and the simultaneous detection of HIV infection via HIV antibody detection' [patent_app_type] => utility [patent_app_number] => 12/454951 [patent_app_country] => US [patent_app_date] => 2009-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10472 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20090258343.pdf [firstpage_image] =>[orig_patent_app_number] => 12454951 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/454951
Semi-quantitative immunochromatographic device and method for the determination of HIV/AIDS immune-status via measurement of soluble CD40 Ligand/CD154, A CD4+ T cell equivalent and the simultaneous detection of HIV infection via HIV antibody detection May 26, 2009 Abandoned
Array ( [id] => 5533059 [patent_doc_number] => 20090232847 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-17 [patent_title] => 'Immunogenic compositions' [patent_app_type] => utility [patent_app_number] => 12/471772 [patent_app_country] => US [patent_app_date] => 2009-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 14782 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20090232847.pdf [firstpage_image] =>[orig_patent_app_number] => 12471772 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/471772
Immunogenic compositions May 25, 2009 Abandoned
Array ( [id] => 5375100 [patent_doc_number] => 20090312661 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-17 [patent_title] => 'DEVICE FOR DETERMINING A CONDITION OF FLOW IN A RESPIRATION SYSTEM' [patent_app_type] => utility [patent_app_number] => 12/469907 [patent_app_country] => US [patent_app_date] => 2009-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 5395 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20090312661.pdf [firstpage_image] =>[orig_patent_app_number] => 12469907 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/469907
Device for determining a condition of flow in a respiration system May 20, 2009 Issued
Array ( [id] => 8737334 [patent_doc_number] => 08409096 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-02 [patent_title] => 'Breathing circuit with embedded acoustic reflectometer' [patent_app_type] => utility [patent_app_number] => 12/469492 [patent_app_country] => US [patent_app_date] => 2009-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 11 [patent_no_of_words] => 5203 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 256 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12469492 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/469492
Breathing circuit with embedded acoustic reflectometer May 19, 2009 Issued
Array ( [id] => 5374185 [patent_doc_number] => 20090311746 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-17 [patent_title] => 'INTERGENIC REGIONS AS INSERTION SITES IN THE GENOME OF MODIFIED VACCINIA VIRUS ANKARA (MVA)' [patent_app_type] => utility [patent_app_number] => 12/468120 [patent_app_country] => US [patent_app_date] => 2009-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 10587 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20090311746.pdf [firstpage_image] =>[orig_patent_app_number] => 12468120 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/468120
Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA) May 18, 2009 Issued
Array ( [id] => 7502323 [patent_doc_number] => 08034354 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-11 [patent_title] => 'Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA)' [patent_app_type] => utility [patent_app_number] => 12/468127 [patent_app_country] => US [patent_app_date] => 2009-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 10669 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 251 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/034/08034354.pdf [firstpage_image] =>[orig_patent_app_number] => 12468127 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/468127
Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA) May 18, 2009 Issued
Array ( [id] => 5464432 [patent_doc_number] => 20090324632 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-31 [patent_title] => 'Methods and reagents for vaccination which generate a CD8 T cell immune response' [patent_app_type] => utility [patent_app_number] => 12/454385 [patent_app_country] => US [patent_app_date] => 2009-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 19595 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0324/20090324632.pdf [firstpage_image] =>[orig_patent_app_number] => 12454385 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/454385
Methods and reagents for vaccination which generate a CD8 T cell immune response May 14, 2009 Abandoned
Array ( [id] => 5457881 [patent_doc_number] => 20090258033 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-15 [patent_title] => 'HCV E1E2 vaccine compositions' [patent_app_type] => utility [patent_app_number] => 12/454074 [patent_app_country] => US [patent_app_date] => 2009-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 17864 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20090258033.pdf [firstpage_image] =>[orig_patent_app_number] => 12454074 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/454074
HCV E1E2 vaccine compositions May 11, 2009 Abandoned
Array ( [id] => 6527450 [patent_doc_number] => 20100015087 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'HIV-1 TAT, OR DERIVATIVES THEREOF FOR PROPHYLACTIC AND THERAPEUTIC VACCINATION' [patent_app_type] => utility [patent_app_number] => 12/436119 [patent_app_country] => US [patent_app_date] => 2009-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 36678 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20100015087.pdf [firstpage_image] =>[orig_patent_app_number] => 12436119 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/436119
HIV-1 Tat, or derivatives thereof for prophylactic and therapeutic vaccination May 5, 2009 Issued
Array ( [id] => 5315933 [patent_doc_number] => 20090280531 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-12 [patent_title] => 'Preparation of Soluble Capsid Proteins of Picornaviruses Using SUMO Fusion Technology' [patent_app_type] => utility [patent_app_number] => 12/436215 [patent_app_country] => US [patent_app_date] => 2009-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2830 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20090280531.pdf [firstpage_image] =>[orig_patent_app_number] => 12436215 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/436215
Preparation of Soluble Capsid Proteins of Picornaviruses Using SUMO Fusion Technology May 5, 2009 Abandoned
Menu